Pulsar-18 Self Expanding Stent

Pulsar-18-750-main.jpg

Pulsar-18 Self Expanding Stent

0.018"/OTW

For use in patients with atherosclerotic disease of the femoral and infrapopliteal arteries

Overview

Pulsar-18

Indicated for use to improve luminal diameter in patients with symptomatic
de novo, restenotic or occlusive lesions located in the superficial femoral
or proximal popliteal arteries, with reference vessel diameters from 3.0
to 6.0 mm and total lesion lengths up to 190 mm.*

*Indication as per IFU.

Thinner struts and lower COF make a difference*

  • 140 μm thin struts. Thinner than the leading US brands1,2
  • Low Chronic Outward Force3
  • Improved acute outcomes4,5

*As demonstrated in pre-clinical studies

Instructions for Use

BIOTRONIK Support

For Instructions for Use (IFU) for this product, please visit Biotronik's product manual library.

All references

  1. 1. Strut thickness for 6.0 mm diameters. Values reflect actual measurement and due to processing tolerances may not align to manufacturers statements. BIOTRONIK data on file;

  2. 2. Leading competitors have been selected based on the USA PV SFA Self-Expanding Stent Revenue Market Share, 2016; (Source: Millennium Research Group Inc.). Latest FDA approved SFA self-expanding stents for each manufacturer;

  3. 3. Chronic Outward Force for 6.0 mm diameters. Supera stent not possible to test due to its design and applied test method;